Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients-Reference-Cited by-同舟云学术

Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients

Published:2022-06 Issue:6 Volume:7 Page:1406-1409
ISSN:2468-0249
Container-title:Kidney International Reports
language:en
Short-container-title:Kidney International Reports

Author:

Spensley Katrina J.^ORCID,Gleeson Sarah,Martin Paul^ORCID,Thomson Tina,Clarke Candice L.,Pickard Graham,Thomas David,McAdoo Stephen P.,Randell Paul,Kelleher Peter,Bedi Rachna,Lightstone Liz,Prendecki Maria,Willicombe Michelle

Publisher

Elsevier BV

Subject

Nephrology

Reference8 articles.

1. The Omicron variant is highly resistant against antibody-mediated neutralization: implications for control of the COVID-19 pandemic;Hoffmann;Cell,2022

2. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron;Shuai;Nature,2022

3. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters;Halfmann;Nature,2022

4. Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients;Carr;Lancet,2022

5. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients;Carr;Lancet,2021

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omicron variant infection worsen the prognosis of haemodialysis (HD) patients;Annals of Medicine;2024-08-25

2. The outcome and related risk factors of unvaccinated patients with end-stage kidney disease during the Omicron pandemic: a multicentre retrospective study;BMJ Open;2024-05

3. SARS-CoV-2 Omicron Infections among Vaccinated Maintenance Hemodialysis Patients: Outcomes and Comparison to Delta Variant;Nephron;2024-03-14

4. Humoral immunity trends in a hemodialysis cohort following SARS‐CoV‐2 mRNA booster: A cohort study;Health Science Reports;2024-02

5. Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis;BMJ Open;2023-12